New-Generation MIGS: Which MIGS for Which Patient? (CME Case Library)

Program Overview

Patients on maximum medical therapy for glaucoma and their physicians are often challenged to select efficacious and safe treatment options that can further lower intraocular pressure while reducing the burden of topical therapy. Several recent advances in the field of glaucoma are capable of meeting these needs, including minimally invasive glaucoma surgery (MIGS) procedures. Both the array of MIGS options and the literature supporting their use are expanding. In this activity, based on a series of live virtual meetings, experts in glaucoma share their experiences with various MIGS procedures and devices and discuss patient selection, comparison of MIGS procedures and devices, and optimization techniques. The desired results of this educational activity are to prepare clinicians to confidently incorporate MIGS into their surgical repertoire and develop the ability to select the best MIGS procedure and device according to individual patient needs and desires.

Target Audience

This educational activity is intended for glaucoma specialists and other ophthalmologists.

Learning Objectives

Upon completion of this activity, participants will be better able to:

  • Apply evidence to select appropriate subconjunctival MIGS procedures for a variety of patients
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation
Course opens: 
02/18/2021
Course expires: 
02/28/2022
Cost:
$0.00

Faculty

imageSahar Bedrood, MD, PhD
Ophthalmologist
Acuity Eye Group
Adjunct Clinical Assistant Professor
USC Roski Eye Institute
Los Angeles County + USC Medical Center
Pasadena, California
 
imageDavinder S. Grover, MD, MPH
President
Dallas Academy of Ophthalmology
Attending Surgeon and Clinician
Glaucoma Associates of Texas
Dallas, Texas
imageLeon W. Herndon Jr, MD
Professor of Ophthalmology
Chief, Glaucoma Division Duke Eye Center
Durham, North Carolina
imageJonathan S. Myers, MD
Director, Glaucoma Service
Wills Eye Hospital
Associate Professor of Ophthalmology
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania
imageArsham Sheybani, MD
Assistant Professor of Ophthalmology
Fellowship Director, Glaucoma and Anterior Segment Surgery
Residency Program Director, Ophthalmology
Washington University in St Louis
St Louis, Missouri

Disclosure Policy Statement

It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Disclosures

Sahar Bedrood, MD, PhD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Avellino Labs; Glaukos Corporation; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Allergan and Glaukos Corporation.

Davinder S. Grover, MD, MPH, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; MicroOptx; New World Medical, Inc; and Reichert, Inc; Contracted Research: Allergan; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Allergan; Bausch & Lomb Incorporated; New World Medical, Inc; and Reichert, Inc.

Leon W. Herndon Jr, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Glaukos Corporation; New World Medical, Inc; Ocular Therapeutix, Inc; and Santen Inc; Contracted Research: Ocular Therapeutix, Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Glaukos Corporation; and New World Medical, Inc; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Sight Sciences.

Jonathan S. Myers, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Allergan; Glaukos Corporation; MicroOptx; and Olleyes Inc; Contracted Research: Aerie Pharmaceuticals, Inc; Allergan; Diopsys, Inc; Glaukos Corporation; Haag-Streit Group; Nicox; Olleyes Inc; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; and Allergan; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Olleyes Inc.

Arsham Sheybani, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Glaukos Corporation; Ivantis Inc; and Santen Inc.

New York Eye and Ear Infirmary of Mount Sinai Peer Review Disclosure

Kateki Vinod, MD, has no relevant commercial relationships to disclose.

Editorial Support Disclosures

Erika Langsfeld, PhD; Cynthia Tornallyay, RD, MBA, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation

The contributing physicians listed above have attested to the following:

  1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
  2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
  3. that all reasonable clinical alternatives will be discussed when making practice recommendations.

Accreditation Statement

imageThe New York Eye and Ear Infirmary of Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity was developed and implemented in collaboration with MedEdicus LLC.

AMA Credit Designation Statement

The New York Eye and Ear Infirmary of Mount Sinai designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grantor Statement

This continuing medical education activity is supported through an unrestricted educational grant from Allergan.

Off-Label Discussion

This CME activity includes discussion of unlabeled and/or investigative uses of drugs and/or devices. Please refer to the official prescribing information for each drug or device discussed in this activity for FDA-approved dosing, indications, and warnings.

New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies

https://www.nyee.edu/education/cme

CME Provider Contact Information

For questions about this activity, call Kim Sponza at 203-461-0222.

To Obtain AMA PRA Category 1 Credit

To obtain AMA PRA Category 1 Credit™ for this activity, view the webcast modules and complete the post test and evaluation. Upon passing, you will receive your certificate immediately. You must score 70% or higher to receive credit for this activity, and may take the test up to 2 times. Upon registering and successfully completing the post test, your certificate will be made available online and you can print it or file it.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of New York Eye and Ear Infirmary of Mount Sinai, MedEdicus LLC, or Allergan.

This CME activity is copyrighted to MedEdicus LLC ©2021. All rights reserved. 220

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Clicking Register indicates that you have reviewed the CME information for this activity.

Learning Method and Medium

This educational activity consists of two (2) webcast modules and one (1) study question. The participant should, in order, read the learning objective, view the webcast modules, answer the question in the post test, and complete the evaluation. To receive credit for this activity, please complete the post test and evaluation. This educational activity should take a maximum of 0.75 hour to complete.